These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Further improvement of orally disintegrating tablets using micronized ethylcellulose. Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. Int J Pharm; 2012 Feb 28; 423(2):351-9. PubMed ID: 22138608 [Abstract] [Full Text] [Related]
10. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets. Late SG, Yu YY, Banga AK. Int J Pharm; 2009 Jan 05; 365(1-2):4-11. PubMed ID: 18778759 [Abstract] [Full Text] [Related]
11. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet. Jung HA, Augsburger LL. Drug Dev Ind Pharm; 2012 Jul 05; 38(7):825-36. PubMed ID: 22091970 [Abstract] [Full Text] [Related]
12. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles. Tahvanainen M, Rotko T, Mäkilä E, Santos HA, Neves D, Laaksonen T, Kallonen A, Hämäläinen K, Peura M, Serimaa R, Salonen J, Hirvonen J, Peltonen L. Int J Pharm; 2012 Jan 17; 422(1-2):125-31. PubMed ID: 22063301 [Abstract] [Full Text] [Related]
13. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation. Sano S, Iwao Y, Kimura S, Itai S. Int J Pharm; 2011 Sep 15; 416(1):252-9. PubMed ID: 21763765 [Abstract] [Full Text] [Related]
14. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets. Alhusban F, Perrie Y, Mohammed AR. Eur J Pharm Biopharm; 2011 Nov 15; 79(3):627-34. PubMed ID: 21693189 [Abstract] [Full Text] [Related]
15. Effect of powder characteristics on oral tablet disintegration. Yamamoto Y, Fujii M, Watanabe K, Tsukamoto M, Shibata Y, Kondoh M, Watanabe Y. Int J Pharm; 2009 Jan 05; 365(1-2):116-20. PubMed ID: 18804156 [Abstract] [Full Text] [Related]